Public Health On Call

741 - Xolair: The First Drug For Severe Food Allergies

04.03.2024 - By Johns Hopkins Bloomberg School of Public HealthPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Xolair is the first FDA-approved therapy to prevent severe and potentially life-threatening reactions in adults and children who are allergic to dairy, eggs, wheat, nuts and other foods. Dr. Robert Wood, the director of pediatric allergy and immunology at Johns Hopkins, talks with Lindsay Smith Rogers about this drug that has the potential to make life a little easier for patients and parents of children with severe allergies.

More episodes from Public Health On Call